Assessing the effects of nucleotide-binding oligomerization domain-containing protein 1 stimulation: Novel target of therapy in models of Inflammatory Bowel Disease.

评估含核苷酸结合寡聚化结构域的蛋白 1 刺激的效果：炎症性肠病模型中的新治疗靶点。

• 批准号: 466573
• 负责人: Nissan Marry A
• 金额: $ 1.27万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-12-01 至 2022-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466573&lang=en
• 关键词: Ibd; Ie-Dap; Ifn?; Inflammatory Bowel Disease; Interferon-?; Nf-?B; Nod1; Nod2; Nuclear Factor Kappa B; Nucleotide-Binding Oligomerization Domain

Inflammatory bowel disease (IBD) is a collection of conditions that result in the inflammation of the gastrointestinal tract causing diarrhea, abdominal pain, weight loss, nausea, and vomiting. With its prevalence a whopping 0.6% in Canada, there is a nee

炎症性肠病 (IBD) 是导致胃肠道炎症的一系列疾病，导致腹泻、腹痛、体重减轻、恶心和呕吐。由于其在加拿大的患病率高达 0.6%，因此有必要